Here, we adopt a meta-analysis approach across six independent FSHD muscle biopsy studies to analyse several FSHD molecular biomarkers based on DUX4 target gene expression, and to compare them to a novel biomarker based on Pax7 target gene repression. Here, DUX4 is linked to facioscapulohumeral muscular dystrophy.